B A Grotenhuis

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi Preoperative assessment of tumor location and station-specific lymph node status in patients with adenocarcinoma of the gastroesophageal junction
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus MC, University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands
    World J Surg 37:147-55. 2013
  2. ncbi Cancer stem cells and their potential implications for the treatment of solid tumors
    B A Grotenhuis
    Erasmus Medical Center, Department of Surgery, Rotterdam, The Netherlands
    J Surg Oncol 106:209-15. 2012
  3. ncbi The sentinel node concept in adenocarcinomas of the distal esophagus and gastroesophageal junction
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    J Thorac Cardiovasc Surg 138:608-12. 2009
  4. ncbi Surgical management of submucosal esophageal cancer: extended or regional lymphadenectomy?
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    Ann Surg 252:823-30. 2010
  5. ncbi Lymphatic micrometastases in patients with early esophageal adenocarcinoma
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    J Surg Oncol 102:863-7. 2010
  6. ncbi Inter- and intraobserver variation in the histopathological evaluation of early oesophageal adenocarcinoma
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus Medical Centre, Rotterdam, The Netherlands
    J Clin Pathol 63:978-81. 2010
  7. ncbi Validation of a nomogram predicting complications after esophagectomy for cancer
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    Ann Thorac Surg 90:920-5. 2010
  8. ncbi The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus MC, University Medical Center, 2040, 3000 CA, Rotterdam, The Netherlands
    Recent Results Cancer Res 182:39-63. 2010
  9. ncbi Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer
    B A Grotenhuis
    Department of Surgery, Erasmus Medical Center, Erasmus University, P O Box 2040, 3000 CA, Rotterdam, The Netherlands
    World J Surg 34:2621-7. 2010
  10. ncbi Preoperative risk assessment and prevention of complications in patients with esophageal cancer
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    J Surg Oncol 101:270-8. 2010

Detail Information

Publications14

  1. ncbi Preoperative assessment of tumor location and station-specific lymph node status in patients with adenocarcinoma of the gastroesophageal junction
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus MC, University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands
    World J Surg 37:147-55. 2013
    ....
  2. ncbi Cancer stem cells and their potential implications for the treatment of solid tumors
    B A Grotenhuis
    Erasmus Medical Center, Department of Surgery, Rotterdam, The Netherlands
    J Surg Oncol 106:209-15. 2012
    ..The aim of this review is to evaluate the current evidence for the existence of CSCs and the implications on the present management and treatment of solid tumors...
  3. ncbi The sentinel node concept in adenocarcinomas of the distal esophagus and gastroesophageal junction
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    J Thorac Cardiovasc Surg 138:608-12. 2009
    ..In this study we investigated whether the application of the sentinel node procedure is feasible in esophageal adenocarcinoma and whether it can tailor surgical treatment of the individual patient...
  4. ncbi Surgical management of submucosal esophageal cancer: extended or regional lymphadenectomy?
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    Ann Surg 252:823-30. 2010
    ....
  5. ncbi Lymphatic micrometastases in patients with early esophageal adenocarcinoma
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    J Surg Oncol 102:863-7. 2010
    ..The study aim was to investigate whether the presence of occult tumor cells in lymph nodes could explain this variation...
  6. ncbi Inter- and intraobserver variation in the histopathological evaluation of early oesophageal adenocarcinoma
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus Medical Centre, Rotterdam, The Netherlands
    J Clin Pathol 63:978-81. 2010
    ..However, the reproducibility of this classification in terms of inter- and intraobserver variability is unclear...
  7. ncbi Validation of a nomogram predicting complications after esophagectomy for cancer
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    Ann Thorac Surg 90:920-5. 2010
    ..In the present study, we externally validated this nomogram in a new cohort of patients who underwent esophagectomy for cancer in a different high-volume center...
  8. ncbi The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus MC, University Medical Center, 2040, 3000 CA, Rotterdam, The Netherlands
    Recent Results Cancer Res 182:39-63. 2010
    ..This review outlines the process of pathogenesis of Barrett's metaplasia and its progression to esophageal adenocarcinoma...
  9. ncbi Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer
    B A Grotenhuis
    Department of Surgery, Erasmus Medical Center, Erasmus University, P O Box 2040, 3000 CA, Rotterdam, The Netherlands
    World J Surg 34:2621-7. 2010
    ..The purpose of this study was to investigate whether BMI is of prognostic value with regard to short-term and long-term outcome in patients who undergo esophagectomy for cancer...
  10. ncbi Preoperative risk assessment and prevention of complications in patients with esophageal cancer
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    J Surg Oncol 101:270-8. 2010
    ..Both anesthetists and surgeons play an important role in intraoperative risk reduction by means of appropriate fluid management and application of optimal surgical techniques...
  11. ncbi Delay in diagnostic workup and treatment of esophageal cancer
    Brechtje A Grotenhuis
    Department of Surgery, Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands
    J Gastrointest Surg 14:476-83. 2010
    ..The aim of this study was to investigate the impact of these delays on outcome in patients with esophageal cancer...
  12. ncbi Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers
    Brechtje A Grotenhuis
    Department of Surgery, Josephine Nefkens Institute, Erasmus Medical Centre, Rotterdam, The Netherlands
    J Pathol 221:379-89. 2010
    ..However, antibodies directed against novel surface antigens are needed to detect subpopulations enriched for CSCs in EA by transplantation assays...
  13. ncbi Treatment outcome in breast cancer patients with ipsilateral supraclavicular lymph node metastasis at time of diagnosis: a review of the literature
    B A Grotenhuis
    Sint Franciscus Gasthuis, Department of Surgery, PO Box 10900, 3004 BA Rotterdam, The Netherlands
    Eur J Surg Oncol 39:207-12. 2013
    ..The aim of this review was to search the recent literature in order to investigate whether the reported treatment outcome of patients with ipsilateral supraclavicular metastases in breast cancer patients justifies this revision...
  14. ncbi Benzopyrene serum concentration after endovenous laser ablation of the great saphenous vein
    T M A L Klem
    Department of Surgery, Sint Franciscus Gasthuis, Rotterdam, The Netherlands
    Vasc Endovascular Surg 47:213-5. 2013
    ..This group of PAH includes the human carcinogen benzo[a]pyrene (B[a]P). This study determined the serum concentration of B[a]P just before and after EVLA...